Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ro 31-7453 in Metastatic Colorectal Cancer
NCT00016250Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Dec 2000
- Primary completion
- Jun 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mkc-1 in metastatic colorectal cancer (mCRC) (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Objective Disease Rate. Started Dec 2000; status: completed.
02
Drugs
mkc-1
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00016250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016250.